Stille AB (STO:STIL)

Market Cap	2.03B
Revenue (ttm)	541.65M
Net Income (ttm)	52.21M
Shares Out	8.99M
EPS (ttm)	5.81
PE Ratio	38.88
Forward PE	24.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,188
Average Volume	5,080
Open	224.00
Previous Close	226.00
Day's Range	224.00 - 230.00
52-Week Range	179.50 - 275.00
Beta	0.68
RSI	56.40
Earnings Date	Jul 17, 2025

About Enfusion

Stille AB develops, manufactures, and distributes medtech products in Sweden and internationally. It operates through the Surgical Instruments and Surgical Tables segments. The Surgical Instruments segment offers surgical scissors, including SuperCut, eye, blepharoplasty, operating, vascular, tenotomy, and face-lift scissors; colon, gall duct, multi-purpose, tangential occlusion, peripheral vascular, and anastomosis clamps; skin and nerve hooks, retractors, rib spreaders, self-retaining and trachea retractors, and nasal specula; and dressing, d...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1841
• Employees: 142
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: STIL

Financial Performance

In 2024, Stille AB's revenue was 569.95 million, an increase of 93.27% compared to the previous year's 294.89 million. Earnings were 58.21 million, an increase of 118.44%.